Home > Press > Livingston Nanotechnology Conference
Abstract:
Dr. Bernard S. Meyerson, IBM Vice President for Strategic Alliances and CTO, IBM Systems and Technology Group, To Keynote at the Third Annual Axiom Capital Management "Livingston Nanotechnology Conference" on December 7, 2007.
Axiom Capital Management and Scott Livingston today announced that the third annual Axiom Capital Management "Livingston Nanotechnology Conference" will feature a keynote presentation by Dr. Bernard Meyerson, IBM (NYSE:IBM) Vice President for Strategic Alliances and CTO, IBM Systems and Technology Group. Dr. Meyerson will discuss innovation in large organizations, and how radical innovation, integrated with radical collaboration, enables mature companies to keep ahead of upstarts.
"We are thrilled to have Dr. Meyerson talk to our group at our annual gathering." said Scott Livingston, Managing Director of Axiom Capital Management and head of the Livingston Group, a division of Axiom Capital Management Inc. focused exclusively on nanotechnology, "Dr. Meyerson is one of a handful of individuals whose contributions to the advancement of semiconductor manufacturing in America has truly been indispensable. We are proud that our annual event brings together leaders like Dr. Meyerson to help our institutional investor and corporate attendees understand the opportunities presented by advances at the nanoscale."
The third annual Axiom Capital Management "Livingston Nanotechnology Conference" is being held on December 7 at the Marriott Financial Center in Downtown New York City. The conference will bring together blue chip corporations, promising startups and leading investors to discuss investment and business trends in nanotechnology. For more information and registration information please visit http://www.axiomcapital.com/nanotech_2007/index.htm .
About Dr. Bernard Meyerson
Dr. Meyerson joined IBM Research as a staff member in 1980, and led the development of silicon, germanium and other high performance technologies over a period of ten years. He subsequently led a series of development organizations within IBM focused on communications and semiconductor technology, from which he created numerous major business endeavors encompassing applications ranging from pervasive wireless enablement (802.11x) to high end data transport.
In 1992, Dr. Meyerson was appointed an IBM Fellow, the company's highest technical honor. He is also a Fellow of the American Physical Society and the IEEE.
Dr. Meyerson became chief technologist of IBM's Technology Group in 2001, and in 2003 assumed operational responsibility for IBM's global Semiconductor Research and Development programs, In that role he led the world's largest semiconductor development consortium, members of which include Sony, Toshiba, AMD, Samsung, Chartered Semiconductor, and Infineon. In December 2005, he was appointed to the position of vice president of Strategic Alliances and CTO of IBM's System Technology Group.
Throughout the years Dr. Meyerson has received numerous awards for his work including: the Materials Research Society Medal, the Electrochemical Society Electronics Division Award, the IEEE Ernst Weber Award, and the IEEE Electron Devices Society J. J. Ebers Award. He was most recently honored in 2007 with the "Lifetime Achievement Award" by SEMI - that association's infrequently bestowed highest honor for innovation in semiconductor technology and manufacturing.
He was cited as "Inventor of the Year" in 1998 by the NY State Legislature, and was recognized in 1999 as "United States Distinguished Inventor of the Year" by the US IP Law Association and the Patent and Trademark office. In 2002, he was elected to the National Academy of Engineering.
Dr. Meyerson, and his team, was the subject of a long-running study on the topic of innovation in large organizations, culminating in the 2001 Harvard Business School Press publication titled: "Radical Innovation; How Mature Companies Can Outsmart Upstarts."
####
About Axiom Capital Management Inc. and the Livingston Group
Axiom Capital Management, Inc. is an NASD registered broker/dealer that works with growth companies and institutional investors and provides corporate finance, prime brokerage and private equity opportunities to a wide range of customers.
The Livingston Group was formed by Scott Livingston, who Joined Axiom Capital Management inc. in 2005 after a fifteen year career on Wall Street, and has been working exclusively on nanotechnology investments since 2002. Mr. Livingston has been called "sharp and highly connected" by the Forbes Wolfe Nanotechnology Report (July 1, 2005) and has been an invited speaker on nanotechnology investment trends at MIT, the Harvard Club, the Nanobusiness Alliance, the Cambridge Healthtech Institute, Nanotechnology.com, the International Business Forum, Albany Nanotech, the Delaware Technology Park, the Business Executives for National Security, Hillary Clinton's Jobs for New York, WXXA Fox 23, Cold Spring Harbor's Dolan DNA Learning Center and has presented to half a dozen state pension leaders across the country. Scott is also the creator of the annual Axiom Capital Management "Livingston Nanotechnology Conference", one of the best attended nanotechnology forums of the year.
For more information, please click here
Contacts:
Steven Wright-Mark
Schwartz Public Relations
212-677-8700 ext. 29
Copyright © Axiom Capital Management Inc.
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
VC/Funding/Angel financing/Loans/Leases/Crowdfunding
Graphene Flagship start-up Bedimensional closes a second €10 million investment round February 10th, 2023
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Events/Classes
A New Blue: Mysterious origin of the ribbontail ray’s electric blue spots revealed July 5th, 2024
Researchers demonstrate co-propagation of quantum and classical signals: Study shows that quantum encryption can be implemented in existing fiber networks January 20th, 2023
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||